Medical devices, healthcare technology and the business of care
510(k) clearance · K260220

Route 92 Medical Full Length 046 Access System

Route 92 Medical, Inc. · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONK260220

What did the FDA decide?

Route 92 Medical, Inc. received a substantially equivalent (SESE) decision for the Full Length 046 Access System under 510(k) number K260220, dated 2026-09-16. The FDA record lists the device classification as Catheter, Percutaneous, Neurovasculature, product code QJP, regulation number 870.1250, with Cardiovascular as the regulation medical specialty and Neurology as the review panel. The application was received 01/26/2026 and is a Traditional 510(k); it was not reviewed by a third party, is not a combination product, and no predetermined change control plan was authorized.

SESE means the device was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The record does not identify the predicate device, the specific components or changes assessed, or the indications for use, so those details remain unknown from this page. The linked summary document was not part of the public information, and no clinical or performance data are reported here.

The applicant address is listed as 155 Bovet Rd., San Mateo, CA 94402, with Kirsten Valley as applicant contact and Denise Aycox as correspondent contact.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 16, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260220
Regulatory pathway
510(k) premarket notification
Product code
QJP
Decision code
SESE
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Percutaneous, Neurovasculature.

Product code
QJP
FDA device class
2

FDA decision timeline

  1. K260220 received

    Application receipt date recorded by FDA.

  2. K260220 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QJP

Product / regulatory recordCompanyPathwayDecision dateSource
Perfuze, Ltd.510(k) clearanceNov 5, 2026FDA
Stryker Neurovascular510(k) clearanceOct 9, 2026FDA
Alembic, LLC510(k) clearanceOct 6, 2026FDA
Cognition Medical Corp.510(k) clearanceOct 2, 2026FDA
Piraeus Medical, Inc.510(k) clearanceSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Route 92 Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
San Mateo, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records